Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
VJOncology had the opportunity to attend to the European Society for Medical Oncology (ESMO) 2022 Congress which was held in Paris, France and virtually between the 9-13th September. Leading experts in oncology presented face-to-face on the latest developments across the field, including updates from CheckMate 914, monarcHER, and more. Stay tuned for the latest coverage of ESMO 2022 with VJOncology where we were live in Paris!
It was lovely to speak with Zeeba Usofi at #ESSO45 to discuss total peritonectomy vs selective peritonectomy in a retrospective cohort of patients with #OvarianCancer
#ESMO26 | Brian Slomovitz (@GynCancerMD) shares results from the KEYNOTE-C93 trial investigating 1L pembrolizumab vs carboplatin + paclitaxel in dMMR advanced/recurrent #EndometrialCancer 💉🩺
November is Gastric and Pancreatic Cancer Awareness Month! 📢
This week's VJOncology podcast brings you highlights in #GastrointestinalCancer from #ESMO26, featuring @FilippoPietran4, Hiroya Taniguchi, Zev Wainberg, @LorenzaRimassa, and @david_tougeron, as they discuss trials
European Society for Medical Oncology Congress 2022
01 September 2022 | Paris, France
VJOncology had the opportunity to attend to the European Society for Medical Oncology (ESMO) 2022 Congress which was held in Paris, France and virtually between the 9-13th September. Leading experts in oncology presented face-to-face on the latest developments across the field, including updates from CheckMate 914, monarcHER, and more. Stay tuned for the latest coverage of ESMO 2022 with VJOncology where we were live in Paris!
It was lovely to speak with Zeeba Usofi at #ESSO45 to discuss total peritonectomy vs selective peritonectomy in a retrospective cohort of patients with #OvarianCancer
#ESMO26 | Brian Slomovitz (@GynCancerMD) shares results from the KEYNOTE-C93 trial investigating 1L pembrolizumab vs carboplatin + paclitaxel in dMMR advanced/recurrent #EndometrialCancer 💉🩺
November is Gastric and Pancreatic Cancer Awareness Month! 📢
This week's VJOncology podcast brings you highlights in #GastrointestinalCancer from #ESMO26, featuring @FilippoPietran4, Hiroya Taniguchi, Zev Wainberg, @LorenzaRimassa, and @david_tougeron, as they discuss trials
The European Society for Medical Oncology (ESMO) 2021 annual meeting has showcased developments, ground-breaking data, and updates on potential new treatments for cancer. View our video interviews with leading experts!